Related Experiment Video
Updated: Aug 20, 2025
09:15
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.5K
Targeted Therapy and Immunotherapy in Melanoma
Jake Lazaroff1, Diana Bolotin1
1Department of Medicine, Section of Dermatology, University of Chicago, The University of Chicago Medicine, 5841 S Maryland Avenue MC 5067, Chicago, IL 60637, USA.
Dermatologic Clinics
|November 21, 2022
Summary
Targeted therapy and immunotherapy have significantly improved outcomes for metastatic melanoma patients. These advanced treatments offer new hope and better prognoses for individuals battling this aggressive cancer.
Area of Science:
- Oncology
- Dermatology
- Cancer Research
Background:
- Metastatic melanoma remains a significant cause of cancer mortality.
- Limited effective treatment options historically contributed to poor patient prognosis.
Purpose of the Study:
- To review the impact of novel targeted therapies and immunotherapies on metastatic melanoma outcomes.
- To highlight advancements in treatment strategies for advanced melanoma.
Main Methods:
- Review of clinical trial data and treatment guidelines.
- Analysis of therapeutic efficacy for BRAF/MEK inhibitors and immune checkpoint inhibitors (PD-1, PD-L1, CTLA-4).
Main Results:
- Targeted therapy with BRAF/MEK inhibitors demonstrates efficacy in specific melanoma subtypes.
- Immunotherapy, including PD-1, PD-L1, and CTLA-4 inhibitors, has revolutionized melanoma treatment.
- Combined therapeutic approaches show promising results in improving patient survival rates.
Conclusions:
- BRAF/MEK inhibition and immune checkpoint inhibitors represent major therapeutic advances for metastatic melanoma.
- These treatments have substantially improved patient prognosis and survival outcomes.
- Further research into combination therapies and resistance mechanisms is warranted.
Related Concept Videos
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
01:27Tumor Immunotherapy
631
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
631
02:50Combination Therapies and Personalized Medicine
5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
01:30Cancer Vaccines
483
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
483
01:30Skin Cancer
4.4K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.4K
02:49Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K